Sabra Health Care remains a Buy, supported by strong SHOP expansion, robust guidance, and a sustainable 5.84% dividend yield. Click to read why SBRA is a Buy.
American Healthcare REIT’s (NYSE: AHR) strong fourth-quarter and full-year results were fueled largely by performance at its ...
American Healthcare REIT (NYSE: EHR) is continuing to grow its senior housing operating portfolio (SHOP) segment amid rising occupancy, revenue – and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results